Likewise, the inhibitor of Akt reversed such effects of CSF in INS-1 cells [48], which revealed that targeting PI3K/AKT signaling pathway is the possible mechanism of CSF in rescuing β-cell damage during DM. This evidence concerns the gene AKT1 and diabetes mellitus.